A Gnadenhutten ovarian cancer survivor marked two years since treatment by completing a half-marathon at the Run for Home in ...

Dr. Premal Thaker reports IMNN-001 shows early survival benefit in ovarian cancer by activating immune response directly in ...

Platinum-based chemotherapy is a standard treatment for ovarian cancer, but its effectiveness can be limited in some cases.

Relacorilant could improve outcomes in platinum-resistant cases ...

Add Yahoo as a preferred source to see more of our stories on Google. #LillyPartner Cancer clinical trials can offer patients access to investigational treatments that can be explored as early as the ...

GLASGOW, Ky. (WBKO) - At just 37 years old, Stephanie Logsdon was diagnosed with stage 3C ovarian cancer. This was back in 2017. Now in remission, she’s sharing her story to let others know what to ...

SAN JUAN, PUERTO RICO -- A novel regimen for platinum-resistant ovarian cancer solidified its role as a treatment option with ...

Add Yahoo as a preferred source to see more of our stories on Google. There's a special event this week to help raise awareness of ovarian cancer. Here's everything you need to know about the 'Runway ...

A study published April 10 in The Lancet reports that the anti-PD-1 immunotherapy pembrolizumab (brand name Keytruda) ...

Dr. Alexander B. Olawaiye presented findings at the 2026 Society of Gynecologic Oncology Annual Meeting showing that adding ...

The average age for an ovarian cancer diagnosis is after 63 ...